Home
Capital Research Global Investors reported a 7.1% stake in Alnylam Pharmaceuticals ALNY · 9,471,181 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7.1%
- Last report
- 5.4% · filed 25/02/13
- Shares held
- 9,471,181 sh
- Class
- Common Stock
- Event date
- 26/03/31
- Filed
- 26/05/14
7.1% stake · +1.7pp from the last report
- Stake
- 7.1%
- Last report
- 5.4%
- Since last report
- +1.7pp
Alnylam Pharmaceuticals trades, last 26 weeks
What else happened in Alnylam Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 03/01~04/30Capital Research Global Investors's other 5% stake reports
- Capital Research Global Investors
5% stakePatria Investments
5% stakePatria Investments
PAX
0% stake
0 sh
0% stake
Filed 09/04
- Capital Research Global Investors
5% stakeBBB Foods
5% stakeBBB Foods
TBBB
7% stake
5,422,899 sh
7% stake
Filed 08/12
- Capital Research Global Investors
5% stakeQuantinuum
5% stakeQuantinuum
QNT
5.3% stake
1,754,325 sh
5.3% stake
Filed 08/12
- Capital Research Global Investors
5% stakeXPO
5% stakeXPO
XPO
7% stake
8,271,824 sh
7% stake
Filed 08/12
- Capital Research Global Investors
5% stakeDominion Energy
5% stakeDominion Energy
D
8.4% stake
73,865,685 sh
8.4% stake
Filed 08/12
